Six liters of an industrial chemical solvent, sometimes known as “coma in a bottle,” were seized by authorities in Philadelphia, according to U.S. Customs and Border Protection officials on Wednesday.
The six liters of liquid ecstasy, also known as gamma-butyrolactone (GBL), were reportedly imported from France in two shipments that were both intercepted on Saturday while they were being transported to a location in Hillsborough County, Florida.
Each shipment contained a plastic container containing an “opaque liquid” known as GBL, which is listed as a Schedule 1 controlled substance by the Department of Justice’s Drug Enforcement Administration.
This indicates that “it has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision,” according to the DEA.
The tweet below confirms the news:
Gamma-hydroxybutyric acid (GHB), a highly addictive depressant that affects the central nervous system and can result in respiratory distress, unconsciousness, or even death, is the chemical component of GBL, according to the DEA.
Officers claimed that whereas GHB is used by sexual predators as a date-rape medication and by bodybuilders to boost growth hormone, GBL is intended to be used as a solvent to remove paint and rust.
The CBP stated that despite the lack of arrests, it “will continue to use our border security authority to search suspect international parcels and intercept dangerous products that could seriously harm American citizens.”
“CBP officers and agents seized an average of 2,895 pounds of dangerous drugs every day at our nation’s air, land and sea ports of entry” in 2022, it said.
You can depend on us to keep you updated if there is any additional information about this piece of news that comes to light. In the meantime, if you follow our Twitter account, you will be able to read the most current updates on news that is important to this subject. If you do not follow our Twitter account, you will not be able to read these updates.
If you’re interested in reading other news, click the following links: